KRW48,150.00
1.83% yesterday
Korea, Jun 27, 08:10 am CET
ISIN
KR7302440003
Symbol
302440
Index
Sector
Industry

SK Bioscience Stock price

KRW48,000.00
+5,000.00 11.63% 1M
-1,950.00 3.90% 6M
-2,400.00 4.76% YTD
-5,300.00 9.94% 1Y
-61,000.00 55.96% 3Y
-121,000.00 71.60% 5Y
-121,000.00 71.60% 10Y
-121,000.00 71.60% 20Y
Korea, Closing price Fri, Jun 27 2025
-1,050.00 2.14%
ISIN
KR7302440003
Symbol
302440
Index
Sector
Industry

Key metrics

Basic
Market capitalization
KRW3.8t
Enterprise Value
KRW3.1t
Net debt
KRW-778.8b
Cash
KRW1.2t
Shares outstanding
78.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.61 | 6.04
EV/Sales
7.67 | 4.81
EV/FCF
negative
P/B
2.08
Financial Health
Equity Ratio
63.39%
Return on Equity
-2.78%
ROCE
-4.31%
ROIC
-3.74%
Debt/Equity
0.22
Financials (TTM | estimate)
Revenue
KRW399.8b | KRW636.8b
EBITDA
KRW-99.2b | KRW6.3b
EBIT
KRW-110.0b
Net Income
KRW-43.9b | KRW-77.6b
Free Cash Flow
KRW-180.1b
Growth (TTM | estimate)
Revenue
7.72% | 138.03%
EBITDA
-1,626.53% | 104.90%
EBIT
-812.90%
Net Income
-291.82% | -54.85%
Free Cash Flow
-282.77%
Margin (TTM | estimate)
Gross
12.93%
EBITDA
-24.81% | 1.00%
EBIT
-27.52%
Net
-10.97% | -12.19%
Free Cash Flow
-45.04%
More
EPS
KRW-559.87
FCF per Share
KRW-2,298.48
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is SK Bioscience a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

SK Bioscience Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a SK Bioscience forecast:

1x Buy
9%
4x Hold
36%
6x Sell
55%

Analyst Opinions

11 Analysts have issued a SK Bioscience forecast:

Buy
9%
Hold
36%
Sell
55%

Financial data from SK Bioscience

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
399,832 399,832
8% 8%
100%
- Direct Costs 348,119 348,119
55% 55%
87%
51,713 51,713
65% 65%
13%
- Selling and Administrative Expenses 100,228 100,228
55% 55%
25%
- Research and Development Expense 66,076 66,076
24% 24%
17%
-99,181 -99,181
1,627% 1,627%
-25%
- Depreciation and Amortization 10,865 10,865
72% 72%
3%
EBIT (Operating Income) EBIT -110,046 -110,046
813% 813%
-28%
Net Profit -43,865 -43,865
292% 292%
-11%

In millions KRW.

Don't miss a Thing! We will send you all news about SK Bioscience directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.

Head office South Korea
CEO Jae-Yong An
Founded 2008
Website www.skbioscience.co.kr

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today